Zura Bio Overview
Zura Bio (ZURA) has a ROE of -59.08%, below the sector sector average of -5.84%.
Get informed when a big investor buys or sells
+ Follow-59.08%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Zura Bio (ZURA) currently reports a ROE of -59.08%. That is below the sector sector average of -5.84%. Use the charts on this page to explore Zura Bio's ROE history and peer comparisons.
Zura Bio's ROE of -59.08% is lower than the its sector sector average of -5.84%. That is roughly 910.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Zura Bio's current -59.08% should be judged against industry norms (sector average: -5.84%) and against ZURA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -59.08%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.84%. From there, open related valuation or income-statement pages for Zura Bio, and consider following ZURA for alerts when major investors trade the stock.
